Commentary: Clinical Importance of Autoantibodies in Pemphigus
Tuffanelli
Arch Dermatol 1982;118:844-845.
ABSTRACT
Reliability of Indirect Immunofluorescence Testing-Reply
Judd et al.
Arch Dermatol 1980;116:1228-1229.
ABSTRACT
The Correlation of Disease Activity and Antibody Titers in Pemphigus
Fitzpatrick and Newcomer
Arch Dermatol 1980;116:285-290.
ABSTRACT
Fate of Pemphigus Antibody Following Successful Therapy: Preliminary Evaluation of Pemphigus Antibody Determinations to Regulate Therapy
O'Loughlin et al.
Arch Dermatol 1978;114:1769-1772.
ABSTRACT
Immunologic Response to A and B Erythrocytic Antigen: Comparison of Responses in Patients With Pemphigus and Systemic Lupus Erythematosus
Stringa et al.
Arch Dermatol 1976;112:489-492.
ABSTRACT
Acantholytic Herpetiform Dermatitis
DeMento and Grover
Arch Dermatol 1973;107:883-887.
ABSTRACT
Pemphigus Treatment with Azathioprine: Clinical and Immunologic Correlation
Roenigk and Deodhar
Arch Dermatol 1973;107:353-357.
ABSTRACT
Titers of Passive Cutaneous Anaphylaxis Antibody and Clinical Activity in Pemphigus
Pasricha et al.
Arch Dermatol 1972;106:19-21.
ABSTRACT
Indirect Cutaneous Immunofluorescence: I. Morphologic Observations in Bullous Diseases, Malignancies, and Connective Tissue Diseases
Burnham and Fine
Arch Dermatol 1972;105:52-58.
ABSTRACT
Chronic Nonhereditary Blistering Disease in Children: Immunofluorescent Studies
Bean et al.
Arch Pediatr Adolesc Med 1971;122:137-141.
ABSTRACT
PEMPHIGUS AND OTHER DISEASES
Beutner
Arch Dermatol 1971;103:107-110.
ABSTRACT